The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

Clearmind Medicine (CMND) announced the filing of an Israeli patent application for its combination therapy of 5-methoxy-2-aminoindane and ...

Caplyta, which J&J got in its acquisition of Intra-Cellular Therapies, netted a clearance in major depressive disorder that’s ...

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...

In everyday language, the word depression is used in diverse ways and can refer to anything from passing feelings of sadness and unhappiness to chronic grief and deep despair. When clinicians and ...

NEW YORK (Reuters Health) - Regular exercise may work as well as medication in improving symptoms of major depression, researchers have found. Sign up here. In a study of 202 depressed adults, ...

Despite the advice of two of the most successful pop anthems of the last two decades, when it comes to depression, no one can ...

A growing body of research suggests that vitamin D may play a subtler role in mood than previously assumed, becoming most ...

A new study reveals that the first 180 days following a depression diagnosis are the most critical for mortality risk, ...